PCLBCL, LT showed highly recurrent mutations of MYD88 (p.L265P variant), PIM1, and CD79B, which are involved in the NF-κB and B-cell receptor signaling pathways, similar to primary central nervous system lymphoma (PCNSL) [14, 15]. Here, MYD88 is linked to primary central nervous system lymphoma.